Full name
NOVOFARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,7 | 1 | 0,4 | -63,7 |
Gross profit (loss) | 0,5 | 1 | 0,2 | -80,5 |
EBITDA | 0,6 | 0,9 | 0,2 | -80,6 |
Short time liabilities | 5,6 | 5,8 | 6,1 | 4 |
Other operating costs | 0,2 | 0,2 | 0,3 | 15,5 |
Equity capital | 1 | 1,4 | 0,6 | -56,6 |
Operating profit (EBIT) | 0,5 | 0,9 | 0,1 | -85,7 |
Assets | 6,8 | 7,6 | 7 | -6,9 |
Net profit (loss) | 0,6 | 0,9 | 0,1 | -84,6 |
Cash | 0 | 0,1 | 0 | -27,3 |
Net income from sale | 27,6 | 31,4 | 33,4 | 6,7 |
Liabilities and provisions for liabilities | 5,8 | 6,2 | 6,4 | 4,2 |
Working assets | 6,5 | 7,2 | 6,7 | -6,9 |
Other income costs | 0 | 0,1 | 0 | -81,9 |
Depreciation | 0,1 | 0,1 | 0,1 | -19,3 |
% | % | % | p.p. | |
Profitability of capital | 54,8 | 66,9 | 23,8 | -43,1 |
Equity capital to total assets | 14,9 | 18,3 | 8,5 | -9,8 |
Gross profit margin | 1,9 | 3,3 | 0,6 | -2,7 |
EBITDA Margin | 2 | 3 | 0,6 | -2,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 74 | 68 | 66 | -2 |
Current financial liquidity indicator | 1.1572526693344116 | 1.2249149084091187 | 1.0970720052719116 | -0,1 |
Net dept to EBITDA | -0.06634566932916641 | -0.06213990971446037 | -0.23298685252666473 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane